SKI Market

Indian Indices

Nifty

22,502.00 35.90
(0.16%)

Sensex

74,005.94 88.91
( 0.12%)

Bank Nifty

48,199.50 83.85
( 0.17%)

Nifty IT

33,438.75 56.90
( 0.17%)

Global Indices

Nasdaq

16,685.97 -12.35
(-0.07%)

Dow Jones

40,003.59 134.21
(0.34%)

Hang Seng

19,553.61 177.08
(0.91%)

Nikkei 225

38,787.38 -132.88
(-0.34%)

Forex

USD-INR

83.47 0.01
(0.01%)

EUR-INR

90.76 0.22
(0.25%)

GBP-INR

105.79 0.36
(0.34%)

JPY-INR

0.54 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Krebs Biochemicals & Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

524518

INE268B01013

-50.2613955

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

KREBSBIO

147.04

EPS(TTM)

Face Value()

Div & Yield %

Back

accelya solutions india ltd

Accelya Solutions India standalone net profit declines 79.97% in the March 2024 quarter

Apr 18,2024

Net profit of Accelya Solutions India declined 79.97% to Rs 7.24 crore in the quarter ended March 2024 as against Rs 36.14 crore during the previous quarter ended March 2023. Sales rose 14.05% to Rs 118.48 crore in the quarter ended March 2024 as against Rs 103.88 crore during the previous quarter ended March 2023.

Particulars	Quarter Ended
	Mar. 2024	Mar. 2023	% Var.
Sales	118.48	103.88	14
OPM %	42.87	40.69	-
PBDT	61.57	45.33	36
PBT	54.33	37.11	46
NP	7.24	36.14	-80

22,502.00 35.90 (0.16%)

74,005.94 88.91 ( 0.12%)

48,199.50 83.85 ( 0.17%)

33,438.75 56.90 ( 0.17%)

16,685.97 -12.35 (-0.07%)

40,003.59 134.21 (0.34%)

19,553.61 177.08 (0.91%)

38,787.38 -132.88 (-0.34%)

83.47 0.01 (0.01%)

90.76 0.22 (0.25%)

105.79 0.36 (0.34%)

0.54 0.00 (0.51%)